Sarepta Therapeutics Inc. (NASDAQ:SRPT) is a commercial-stage biopharmaceutical company that discovers and develops ...

and a significant deviation from zero would signal PV or CPV, respectively. Searches for CPV with triple-product asymmetries are particularly suited to Λ b 0 four-body decays to hadrons with no ...